As the world races to build artificial superintelligence, one maverick bioengineer is testing how much unprogrammed intelligence may already be lurking in our simplest algorithms to determine whether ...
Plerixafor, a reversible CXCR4 antagonist, significantly increases the yield of CD34 + peripheral blood cells in randomized studies, thereby enabling more patients to proceed to autologous transplant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback